S.‐F. Hsu Schmitz

Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)

Michele Ghielmini, Kaspar Rufibach, Gilles Salles et al. · Annals of Oncology · 2005 · 161 citations · Full text

Medicine, Immunology, Oncology +8

The effect of Rituximab on patients with follicular and mantle-cell lymphoma

Michele Ghielmini, S.‐F. Hsu Schmitz, Kurt Bürki et al. · Annals of Oncology · 2000 · 114 citations · Full text

Medicine, Hematology, Immunology +11

Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment

A Glaus, Ch. Boehme, Beat Thürlimann et al. · Annals of Oncology · 2006 · 88 citations · Full text

Medicine, Gynecology, Oncology +16

Treatment of hairy cell leukemia with cladribine(2-chlorodeoxyadenosine) by subcutaneous bolus injection:a phase II study

A. von Rohr, S.‐F. Hsu Schmitz, André Tichelli et al. · Annals of Oncology · 2002 · 57 citations · Full text

Medicine, Oncology, Pharmacology +14

Cladribine (2‐CDA) given as subcutaneous bolus injections is active in pretreated Waldenström's macroglobulinaemia

Daniel Betticher, S.‐F. Hsu Schmitz, Daniel Ratschiller et al. · British Journal of Haematology · 1997 · 51 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13